De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Kun Peng International Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Kun Peng International's earnings have been declining at an average annual rate of -25.9%, while the Healthcare industry saw earnings growing at 6.2% annually. Revenues have been declining at an average rate of 27.8% per year.
Belangrijke informatie
-25.9%
Groei van de winst
-13.5%
Groei van de winst per aandeel
Healthcare Groei van de industrie | 8.5% |
Inkomstengroei | -27.8% |
Rendement op eigen vermogen | n/a |
Nettomarge | -21.4% |
Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Geen updates
Recent updates
Opbrengsten en kosten
Hoe Kun Peng International geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Jun 24 | 4 | -1 | 5 | 0 |
31 Mar 24 | 4 | -2 | 6 | 0 |
31 Dec 23 | 4 | -2 | 6 | 0 |
30 Sep 23 | 4 | -2 | 6 | 0 |
30 Jun 23 | 1 | -4 | 5 | 0 |
31 Mar 23 | 2 | -3 | 4 | 0 |
31 Dec 22 | 3 | -3 | 6 | 0 |
30 Sep 22 | 8 | -2 | 8 | 0 |
30 Jun 22 | 10 | 0 | 9 | 0 |
31 Mar 22 | 10 | -1 | 10 | 0 |
31 Dec 21 | 10 | -1 | 9 | 0 |
30 Sep 21 | 6 | -2 | 6 | 0 |
30 Jun 21 | 3 | -2 | 5 | 0 |
31 Mar 21 | 3 | -1 | 3 | 0 |
31 Dec 20 | 1 | 0 | 2 | 0 |
30 Sep 20 | 1 | 0 | 1 | 0 |
Kwaliteitswinsten: KPEA is currently unprofitable.
Groeiende winstmarge: KPEA is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: KPEA is unprofitable, and losses have increased over the past 5 years at a rate of 25.9% per year.
Versnelling van de groei: Unable to compare KPEA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: KPEA is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (8%).
Rendement op eigen vermogen
Hoge ROE: KPEA's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.